Il gruppo AGILE (Italian Group for Advanced Laparoscopic and Roboticurologic Surgery) è un gruppo di studio e di formazione composto da giovani urologi.
❤️ kidney surgery. 5th masterclass in robotic partial and radical nephrectomy. No one does live kidney surgery as well as the Italians! 4 kidney cases simultaneously MP& SP. 3D models @Medics3D@bernardorocco73@minerviniandre@AleAntinelli
🔬The evolution of medical publishing is transforming patient care! @RicBertolo explore key shifts: clinician scientists' dual role, #AI's promise & risks, and new metrics for research relevance. Balancing accessibility with integrity is essential. https://t.co/pxP4C2UCQd
The fifth edition of the MASTER CLASS #RAPN / #RARN is bound to happen!
⏰ It’s only 30 days away!
Florence, November 28th and 29th 2024
Congress Presidents: Prof. Andrea Minervini, Prof. Alessandro Antonelli, Prof. Bernardo Rocco.
@minerviniandre@aleantonellibs1@bernardorocco73
Sign up on: https://t.co/mnOQg7CJ1E
15 free spots left❗️
#Urology #RenalSurgery #Nefrectomy #RoboticSurgery #RoboticNephrectomy
Just published in @UrolOncol a hypothesis-generating study by the @UniVerona#Urology team:
Lateral wall tumor location at TURB would predict higher % of ipsilateral positive lymph-nodes s/p cystectomy.
Our findings suggest lateral tumors would need focused lymph-nodes evaluation.
Link to open-access full-text:
https://t.co/SJSgsGsvvx
Take care of your suture in #robotic partial #nephrectomy! Watch here how useful was releasing the last stitch to re-perfuse an ischemic area caused by excessive tension on the suture
🎥 Join Dr. @Ruben_De_Groote at @orsiacademy for WRSE12: Single Port vs. Multiport – The Sequel on October, 15! 🚀 Dive into cutting-edge techniques, expert insights, and live surgeries that challenge the norm.
🚨 Secure your spot for this FREE, online event on our website!
The fifth edition of the MASTER CLASS RAPN/RARN is bound to happen!
Florence, November 28th and 29th 2024 📆
Congress presidents: Prof. Andrea Minervini, Prof. Alessandro Antonelli, Prof. Bernardo Rocco.
➡️ Sign up on: https://t.co/mnOQg7Cbc6
@minerviniandre@aleantonellibs1@bernardorocco73
Out on @MUN_journal, prospective study from the @UniVerona Prof. Antonelli’s team (the COMPAR-P trial): Outcomes of #DaVinci vs #HugoRAS 🤖 #Prostatectomy
🩺 Comparable postoperative complications
🔬 Similar pathology data
📉 No difference in health-related #QoL
#ProstateCancer #Urology #RARP #Surgery #Outcomes #ProspectiveStudy
🔗 https://t.co/K1zTkl3NLW
Kudos to @AleVeccia88 for leading the team and publishing this SR & MA on @UrolOncol.
Radical #cystectomy with #stentless urinary diversion was systematically reviewed to evaluate surgical #outcomes, postoperative complications, and sequelae.
Our analysis found no statistically significant differences between stentless and stented urinary diversion groups, though the stent group had higher odds for major postoperative #complications (OR 3.00 - 95%CI 1.06; 8.52; P = 0.04).
Link to full text -> https://t.co/9QXEg3h333
Excited to announce the 13th edition of #TUM .
Join us on January 30-31, 2025 for two days of groundbreaking technological advancements in urological surgery!
https://t.co/rMWBZQ2Jn3🖌️
@PorpigliaF
Many reasons why perhaps SABR may not be ready 4 prime time 1. solitary kidney tumors /complex tumors need to be treated at high volume centers.. not SABR🏥 2. AS is an option 3. definition of "unfit" for surgery by a urologist is not a good definition I am open to change if someone shows me good data #kidneycancer @CleClinicUro@Uroweb@EurUrolOncol@AmerUrological